Top Vaccine Manufacturer List

The Vaccine market is blooming all over the world. It has become a blockbuster which acquires a market of more than $30 billion. With its Renaissance, researches are being done to prevent against the deadliest diseases like cancer and HIV. The surge is due to the advancements in genomics, medical technologies, and high demand from the developing economies. The market has the potential to be a blockbuster among the consumers.

Vaccine plays a prime role in the frontline health care. The vaccine developers focus on their volume of growth rather than new production. Billions of children are vaccinated worldwide. But, in the developed countries like the US, the growth relies on finding more disease for immunization. As per the “Global Vaccine Market Outlook 2020” market would grow around 12% by 2020.

New magical vaccines for HIV, cancer, meningitis B are on their way. The leaps and a bound increase in the vaccine segment have altered the mind of policymakers. As per them, the exponential increment is piling up new costs to the budget-constrained health system. The economic benefits of the vaccine would easily outweigh the price of medical treatments. In future, the cost of the disease can be 20 times more than the vaccination cost.

Here, we present the top 10 Vaccine Manufacturer list based on their vaccine revenues. These companies have acquired approximately 80% of the vaccine sales and are bound to grow exponentially in future.

  • Glaxo SmithKline

A British pharmaceutical industry headquartered in London. The company manufactures protection against 22 diseases. It has vaccines for all age groups. GSK has come up with vaccines for the most devastating diseases like a pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough, and influenza.The industry is on its way to save the world against the life-threatening diseases HIV, TB and Ebola. As per the global revenues in 2016, it has made a profit of $7.1 billion. The top vaccines were Infanrix/Pediarix, Hepatitis, and Meningitis. GSK went for a joint venture with Indian vaccine company Biological E. With this collaboration, it developed a 6-in-1 vaccine against polio, diphtheria, tetanus, whooping cough, hepatitis B and Haemophilus influenza b.

  • Merk

Merck was known as one of the top vaccine manufacturers because of the vaccine Gardasil. Gardasil is a vaccine shot given to 9 to 26-year-old girls to prevent them from cervical, vaginal, vulvar, and anal cancers and genital warts. Later, they further launched an advancement called Gardasil 9 to provide 90% prevention from cervical cancers. In the year 2013, Merk made another successful trio M-M-R, Varivax and ProQuad, which protects against measles, mumps, rubella and varicella. Merk made a market of $6 billion last year.

  • Pfizer

Pfizer is another top manufacturer of vaccine all over the world. The vaccines made by them focus on the prevention of pneumococcal disease in all age groups. They are brushing their hands on the vaccines for the life-threatening adolescent and adult infections. Out of them are meningococcal disease, Staphylococcus aureus and Clostridium difficult. Pfizer made a market revenue of $6 billion in the last year.

  • Sanofi

Sanofi is yet another high-quality vaccine manufacturer. It’s the leading provider of inactivated poliomyelitis vaccine. It provides the vaccines for travelers and people in tropical areas. Some of these vaccines are typhoid, rabies, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, hepatitis A, and hepatitis B. Sanofi made a market revenue of $5 billion in 2016.

  • CSL

CSL is a global biotech company. It laid its feet in the vaccine segment by developing a tetanus vaccine. Later, CSL made an overwhelming trio vaccine for diphtheria, tetanus and whooping cough. It’s the second largest producer of Influenza vaccine globally. CSL vaccine for Swine Flu was accepted by Australia and is one of the largest national vaccine programs there. The company made a revenue of $772 million last year.

  • Emergent Bio solutions

Emergent Bio Solutions is a multinational pharmaceutical company. The commendable product of Emergent Bio Solution is BioThrax (Anthrax Vaccine Adsorbed). It is the only anthrax vaccine that is licensed by the U.S. Food and Drug Administration. The company made a revenue market of $238 million last year.

  • Novavax

Novavax is the manufacturer of recombinant vaccines. The technology is highlighted to make a vaccine for respiratory syncytial virus (RSV) that is a leading cause of death in infants and old age adults. The company is known by its name NVAX, it completed its Phase I trial for its Ebola vaccine recently. In the year 2016, it made a market of $380 million.

  • Mitsubishi Tanabe

Mitsubishi Tanabe is a developing pharmaceutical company. The company launched a vaccine named MT-2301. It is a Haemophilus influenza type b liquid vaccine. MT-2301 is used widely in Japan. Mitsubishi Tanabe is also the producer of Plant-based VLP vaccines. The VLP vaccines encompass a range of Influenzas. VLPs are bound to provide a high level of immunization effect inside the body. They neither have the virus gene nor the virus replicates inside the body. This unique feature of Mitsubishi vaccine s prompt to draw the attention of many. In the last year, Mitsubishi made a revenue of $345 million.


Please enter your comment!
Please enter your name here

twelve − two =